< Back to catalogue
Cinacalcet/Pharmazac®
2 Νοεμβρίου, 2023Alvoda®
14 Ιουλίου, 2026PHARMAZAC
Abiraterone/Pharmazac
Abiraterone | Antineoplastic | Oncology
| ABIRATERONE/PHARMAZAC 500MG/TAB x 60 x 1ΤΑΒ |
| ABIRATERONE/PHARMAZAC 500MG/TAB x 60 x 1ΤΑΒ |
| ACTIVE SUBSTANCE | |
|---|---|
| BUSINESS UNIT | |
| MARKETING AUTHORISATION HOLDER | Pharmazac S.A. |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| THERAPEUTIC AREA |
